Orexigen Therapeutics Inc. said Monday that in three large late-stage studies its obesity-drug candidate Contrave met its main goals and also surpassed a Food and Drug Administration requirement for effectiveness. The San Diego-based company said it plans to seek FDA approval for Contrave in early 2010.
Orexigen Obesity Drug Trials Successful in 3 Studies
Orexigen Therapeutics Inc. said Monday that in three large late-stage studies its obesity-drug candidate Contrave met its main goals and also surpassed a Food and Drug Administration requirement for effectiveness. The San Diego-based company said it plans to seek FDA approval for Contrave in early 2010.
Sponsers
Search Engine Optimization and SEO Tools
Get more followers
Search Engine Submission - AddMe
Free Blog Promotion - Blog and Blog resource Directory
Irish Blogs Directory
Share
Free Website Directory, Submit Your Site
EasyHits4U.com - Your Free Traffic Exchange - 1:1 Exchange Ratio, 5-Tier Referral Program. FREE Advertising!
Free Search Engine Submission
